NovoCure NVCR
NASDAQ NVCR
$14.94 -0.98 (-6.16%)
At close: Oct 2, 2026 · 4:00 PM EDT

NovoCure (NVCR) Return on Sales [ROS] (2014 - 2026)

Updated

NovoCure's Return on Sales [ROS] came in at -5.75% for Q2 2026, up 19.13 percentage points from -24.89% a year earlier and up 32.98 percentage points from the prior quarter.

Analysis

NovoCure (NVCR) Return on Sales [ROS] (2014 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, NovoCure reported Return on Sales [ROS] of -22.08%, up 5.34 percentage points year-over-year; for FY2025, it was -23.47%, up 4.70 percentage points from FY2024.

  • Return on Sales [ROS] carries a five-year change of -29.62 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Sales [ROS] was -28.17% in FY2024 (+17.55 pp), -45.72% in FY2023 (-29.08 pp), -16.64% in FY2022 (-8.36 pp) and -8.29% in FY2021 (-14.44 pp).
  • The Q2 2026 figure represents the highest quarterly Return on Sales [ROS] since Q1 2022.
  • Year-over-year, Return on Sales [ROS] increased in four of the last eight quarters, with an average year-over-year change of +5.94 percentage points.
  • The fastest year-over-year change in Return on Sales [ROS] over five years came in Q2 2024 (a gain of 27.38 percentage points), and the weakest in Q1 2023 (a drop of 48.72 percentage points).
  • Business Quant data shows NVCR's Return on Sales [ROS] at -38.73% (Q1 2026), -23.17% (Q4 2025) and -21.54% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Thermo Fisher Scientific 242.18 Bn 221.33 Bn 4.88 Bn 17.40%
2 Abbott Laboratories 168.71 Bn 139.79 Bn 7.27 Bn 13.44%
3 Danaher 150.46 Bn 134.27 Bn 3.61 Bn 17.99%
4 Intuitive Surgical 138.71 Bn 118.26 Bn 1.96 Bn 33.60%
5 Medtronic 110.54 Bn 76.41 Bn 6.34 Bn 18.08%
6 Stryker 105.66 Bn 91.78 Bn 4.50 Bn 25.18%
7 Boston Scientific 61.74 Bn 56.75 Bn 3.85 Bn 21.65%
8 Edwards Lifesciences 49.09 Bn 33.21 Bn 1.35 Bn 29.48%
9 Becton Dickinson 48.16 Bn 45.31 Bn 2.32 Bn 13.31%
10 NovoCure 1.74 Bn -614.09 Mn 142.48 Mn -5.75%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -5.75%
Mar 31, 2026 -38.73%
Dec 31, 2025 -23.17%
Sep 30, 2025 -21.54%
Jun 30, 2025 -24.89%
Mar 31, 2025 -24.43%
Dec 31, 2024 -39.25%
Sep 30, 2024 -20.69%
Jun 30, 2024 -22.33%
Mar 31, 2024 -29.98%
Dec 31, 2023 -38.66%
Sep 30, 2023 -45.75%
Jun 30, 2023 -49.71%
Mar 31, 2023 -49.31%
Dec 31, 2022 -33.46%
Sep 30, 2022 -18.79%
Jun 30, 2022 -15.00%
Mar 31, 2022 -0.59%
Dec 31, 2021 -17.56%
Sep 30, 2021 -6.40%
API Access

NovoCure Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=NVCR&period=max&api_key=YOUR_API_KEY